GSA Capital Partners’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-208,016	Closed	-$1.14M	–	2167
2025 Q4	$1.14M	Sell	208,016 -269,733	-56%	-$1.31M	0.1%	289
2025 Q3	$1.56M	Buy	477,749 +433,059	+969%	+$1.23M	0.13%	163
2025 Q2	$103K	Buy	+44,690	New	+$97.1K	0.01%	1612
2024 Q4	–	Sell	-233,560	Closed	-$469K	–	2040
2024 Q3	$469K	Buy	233,560 +91,755	+65%	+$201K	0.04%	946
2024 Q2	$318K	Buy	+141,805	New	+$413K	0.02%	1247
2023 Q3	–	Sell	-18,077	Closed	-$12K	–	1916
2023 Q2	$12K	Sell	18,077 -9,261	-34%	-$6.71K	﹤0.01%	1453
2023 Q1	$22K	Sell	27,338 -156,519	-85%	-$202K	﹤0.01%	1425
2022 Q4	$416K	Sell	183,857 -52,263	-22%	-$106K	0.05%	714
2022 Q3	$456K	Buy	236,120 +49,640	+27%	+$180K	0.06%	642
2022 Q2	$694K	Buy	186,480 +69,371	+59%	+$275K	0.1%	310
2022 Q1	$764K	Buy	117,109 +76,224	+186%	+$570K	0.1%	297
2021 Q4	$476K	Buy	+40,885	New	+$617K	0.06%	635
2020 Q4	–	Sell	-20,000	Closed	-$448K	–	1600
2020 Q3	$448K	Buy	+20,000	New	+$470K	0.07%	464